EXAGEN INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Exagen Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • Exagen Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.85M, a 35.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.85M -$1.56M -35.3% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $3.07M -$1.58M -34% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $3.29M -$1.6M -32.7% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $4.17M -$946K -18.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $4.41M -$926K -17.3% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $4.65M -$982K -17.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $4.89M +$4.89M Dec 31, 2022 10-K 2024-03-18
Q3 2022 $5.11M Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $5.34M Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 $5.63M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.